Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Equity Average (2016 - 2025)

Biomerica's Equity Average history spans 15 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Equity Average fell 8.32% year-over-year to $4.8 million; the TTM value through Nov 2025 reached $4.8 million, down 8.32%, while the annual FY2025 figure was $5.3 million, 41.6% down from the prior year.
  • Equity Average for Q4 2025 was $4.8 million at Biomerica, up from $4.6 million in the prior quarter.
  • Across five years, Equity Average topped out at $11.2 million in Q3 2023 and bottomed at $4.6 million in Q3 2025.
  • The 5-year median for Equity Average is $8.5 million (2022), against an average of $7.8 million.
  • The largest annual shift saw Equity Average surged 169.94% in 2021 before it plummeted 48.09% in 2024.
  • A 5-year view of Equity Average shows it stood at $8.9 million in 2021, then fell by 12.08% to $7.8 million in 2022, then rose by 29.46% to $10.1 million in 2023, then tumbled by 48.09% to $5.2 million in 2024, then decreased by 8.32% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Equity Average are $4.8 million (Q4 2025), $4.6 million (Q3 2025), and $4.8 million (Q2 2025).